1. Home
  2. ALT vs DSU Comparison

ALT vs DSU Comparison

Compare ALT & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • DSU
  • Stock Information
  • Founded
  • ALT 1997
  • DSU 1998
  • Country
  • ALT United States
  • DSU United States
  • Employees
  • ALT N/A
  • DSU N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • DSU Finance Companies
  • Sector
  • ALT Health Care
  • DSU Finance
  • Exchange
  • ALT Nasdaq
  • DSU Nasdaq
  • Market Cap
  • ALT 472.3M
  • DSU 519.1M
  • IPO Year
  • ALT N/A
  • DSU N/A
  • Fundamental
  • Price
  • ALT $4.14
  • DSU $10.63
  • Analyst Decision
  • ALT Strong Buy
  • DSU
  • Analyst Count
  • ALT 6
  • DSU 0
  • Target Price
  • ALT $20.20
  • DSU N/A
  • AVG Volume (30 Days)
  • ALT 10.1M
  • DSU 148.2K
  • Earning Date
  • ALT 08-07-2025
  • DSU 01-01-0001
  • Dividend Yield
  • ALT N/A
  • DSU 10.06%
  • EPS Growth
  • ALT N/A
  • DSU N/A
  • EPS
  • ALT N/A
  • DSU N/A
  • Revenue
  • ALT $20,000.00
  • DSU N/A
  • Revenue This Year
  • ALT N/A
  • DSU N/A
  • Revenue Next Year
  • ALT $1,557,547.90
  • DSU N/A
  • P/E Ratio
  • ALT N/A
  • DSU N/A
  • Revenue Growth
  • ALT N/A
  • DSU N/A
  • 52 Week Low
  • ALT $2.90
  • DSU $9.22
  • 52 Week High
  • ALT $11.16
  • DSU $11.40
  • Technical
  • Relative Strength Index (RSI)
  • ALT 33.67
  • DSU 59.70
  • Support Level
  • ALT $3.30
  • DSU $10.36
  • Resistance Level
  • ALT $4.04
  • DSU $10.64
  • Average True Range (ATR)
  • ALT 0.61
  • DSU 0.08
  • MACD
  • ALT -0.40
  • DSU 0.01
  • Stochastic Oscillator
  • ALT 19.49
  • DSU 82.14

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.

Share on Social Networks: